Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Nine-Inch Hair: Cancer's Battle Scar

January 28th 2019

Outwardly, you start to look like your old self again while inside you're still licking the wounds of your cancer battle.

Insight on Novel Therapies in Follicular Lymphoma

January 21st 2019

Practical Advice for Patients With Newly Diagnosed FL

January 21st 2019

Multidisciplinary Management of Follicular Lymphoma

January 21st 2019

Preparing Patients for PI3K Infusion-Based Therapy

January 21st 2019

Managing Gerald Through a Relapse of Follicular Lymphoma

January 21st 2019

Gerald's Journey Through Follicular Lymphoma

January 21st 2019

Considerations in the Diagnosis of Follicular Lymphoma

January 21st 2019

A Brighter Future for Blood Cancers

January 7th 2019

Toronto’s Jeff Lipton, PhD, MD, FRCPC, shares his thoughts on the outlook for blood cancers.

Cord Blood Transplantation Provides 'Donor for Every Patient'

January 5th 2019

In an interview with CURE, Filippo Milano, M.D., Ph.D., explains what cord blood transplantation is and why it is important for patients to learn more.

Handing a Piece of Life Back

January 3rd 2019

Laurie was no stranger to cancer after she faced a bout with stage 3b non-Hodgkin lymphoma back in 1977, but her second diagnosis of breast cancer left her with a very tough decision on how she wanted to move forward with treatment.

Some Patients with Lymphoma May Benefit from Reduced Chemotherapy

December 28th 2018

As researchers recently discovered, outcomes for patients with diffuse large B-cell lymphoma are just as good when the number of chemotherapy cycles is reduced.

The Spanish Steps

December 28th 2018

How to conquer the fear of your own body, one step at a time.

'Healing Hope' After Cancer

December 20th 2018

WE SURVIVORS ARE INUNDATED with the message: “Be hopeful!” Unfortunately, that universal rallying cry doesn’t help us know how to find hope or what to hope for.

Co-Founder of Microsoft Died of Blood Cancer

December 16th 2018

PAUL ALLEN, A COFOUNDER of Microsoft, died of the blood cancer non-Hodgkin lymphoma on Oct. 16.

Kymriah Yields Durable Response in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

December 6th 2018

Long-term follow-up of the JULIET trial showed patients with relapsed or refractory DLBCL continued to experience durable responses 19 months after treatment.

My Candle in the Wind: Remembering a Loss to Hodgkin's Lymphoma

December 5th 2018

Especially during holiday seasons, we remember loved ones who are not with us. Even long after they have passed, we can cherish old memories and even make new ones with the help of social media. Recently I learned something sweet about my brother John, who died of Hodgkin's lymphoma decades ago, from a high school friend I never knew about.

At-Home Blood Thinner Use During Systemic Therapy May Decrease Risk for Clots

December 5th 2018

Treatment with Xarelto (rivaroxaban) may reduce the risk for developing blood clots during active treatment with a systemic therapy like chemotherapy, according to results from the CASSINI trial.

FDA Approves First Biosimilar to Treat Non-Hodgkin Lymphoma

November 29th 2018

The Food and Drug Administration (FDA) approved Truxima (rituximab-abbs) – the first biosimilar of Rituxan (rituximab) – to treat adults with CD20-positive, B-cell non-Hodgkin lymphoma (NHL).

No Road Is Too Rocky for This Survivor

November 28th 2018

Jeff Young, D.V.M., refused to let cancer stop him from living.

FDA Approves Adcetris Plus Chemo for Peripheral T-cell Lymphoma

November 16th 2018

The Food and Drug Administration (FDA) expedited the approval of Adcetris (brentuximab vedotin) in combination with chemotherapy for certain patients with peripheral T-cell lymphoma (PTCL).

FDA Grants Adcetris a Breakthrough Therapy Designation for Rare Lymphoma

November 15th 2018

The Food and Drug Administration (FDA) granted a breakthrough therapy designation to Adcetris (brentuximab vedotin) for the frontline treatment of certain lymphoma subtypes, according to Seattle Genetics, the manufacturer of the antibody-drug conjugate.

Researchers Identify Risk Factors of Chemotherapy Side Effect

November 14th 2018

Preventing febrile neutropenia is crucial because the body’s white blood cells help to fight infection.

Clinical Trial Results Leave Treatment Questions Unanswered for Certain Lymphomas

November 13th 2018

Lawrence D. Kaplan, M.D., discusses recent updates and next steps to be taken in Hodgkin, mantle cell and follicular lymphoma.

Single Agent Entospletinib Induces Modest Activity in Lymphoma Subgroups

November 13th 2018

Entospletinib monotherapy yielded limited activity in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.

FDA Grants Fast Track Designation to Selinexor to Treat Diffuse Large B-cell Lymphoma

November 7th 2018

The Food and Drug Administration (FDA) granted fast track designation to selinexor for the treatment of patients with diffuse large B-cell lymphoma (DLBCL), according to Karyopharm Therapeutics, the drug’s manufacturer.

Therapy Combination May Have Value as a Treatment For Slow-Growing B-Cell Lymphomas

October 29th 2018

People with slow-growing B-cell lymphomas and no symptoms are often prescribed a watch-and-wait approach, which involves monitoring until the disease grows and warrants treatment.

Adcetris, Chemotherapy Regimen Benefits Older Patients With Hodgkin Lymphoma

October 29th 2018

Treating older patients who have Hodgkin lymphoma with Adcetris (brentuximab vedotin) before and after chemotherapy showed improved remission and survival rates, according to phase 2 study findings.

FDA Grants Priority Review to Jakafi for Acute Graft-Versus-Host-Disease

October 26th 2018

The Food and Drug Administration has granted a priority review to the supplemental new drug application for Jakafi (ruxolitinib) to treat patients with acute graft-versus-host-disease (GVHD) who have had an inadequate response to corticosteroids.

'Bringing Hope Home' After a Cancer Diagnosis

October 24th 2018

When Paul Isenberg’s wife, Nicole, was diagnosed with stage 4 Hodgkin lymphoma shortly after the birth of their child, Gabrielle, the couple realized two things: how blessed they were and that some people going through cancer have nobody to turn to.